首页> 外文期刊>Sleep medicine >Comparison of severity of obstructive sleep apnea and degree of accumulation of cardiac 123I-MIBG radioactivity as a diagnostic marker for idiopathic REM sleep behavior disorder.
【24h】

Comparison of severity of obstructive sleep apnea and degree of accumulation of cardiac 123I-MIBG radioactivity as a diagnostic marker for idiopathic REM sleep behavior disorder.

机译:比较阻塞性睡眠呼吸暂停的严重程度和心脏123I-MIBG放射性的累积程度作为特发性REM睡眠行为障碍的诊断指标。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: We investigated cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigraphic assessment as a supportive diagnostic indicator for idiopathic REM sleep behavior disorder (RBD) complicated by moderate to severe obstructive sleep apnea (OSA). METHODS: (123)I-MIBG was intravenously injected in 23 idiopathic RBD patients with AHI < 5/h, 9 idiopathic RBD patients with 5 or= 15/h, and 16 moderate to severe obstructive sleep apnea syndrome (OSAS) patients without RBD by polysomnography. RESULTS: Cardiac MIBG uptake based on H/M was significantly decreased in RBD patients with or without OSA compared with patients with moderate to severe OSAS without RBD. ROC analysis revealed that a delayed H/M cut-off value of 1.97 was useful for differentiating idiopathic RBD complicated by moderate to severe OSA from moderate to severe OSAS without RBD. CONCLUSIONS: (123)I-MIBG cardiac scintigraphy has the potential to distinguish true RBD from pseudo-RBD associated with OSA. These results are noteworthy because treatment options and follow-up protocols are determined based on evaluation of moderate to severe OSA complicated with RBD, such as overlapping primary sleep disorders.
机译:目的:我们调查了心脏(123)I-甲氧苄基胍(MIBG)闪烁显像评估作为特发性REM睡眠行为障碍(RBD)并发中度至重度阻塞性呼吸暂停(OSA)的支持性诊断指标。方法:(123)I-MIBG静脉注射23例AHI <5 / h的特发性RBD患者,9例5≤AHI <15 / h的特发性RBD患者,15例中重度OSA并发AHI的特发性RBD患者>或= 15 / h,通过多导睡眠监测仪分析16例无RBD的中重度阻塞性睡眠呼吸暂停综合征(OSAS)患者。结果:与有或无OSA的中度至重度OSAS患者相比,有或没有OSA的RBD患者基于H / M的心脏MIBG摄取显着降低。 ROC分析显示,延迟的H / M截止值为1.97可用于区分特发性RBD并发中度至重度OSA与无RBD的中度至重度OSAS。结论:(123)I-MIBG心脏闪烁显像术有可能将真正的RBD与与OSA相关的假RBD区分开。这些结果值得注意,因为根据中度至重度OSA并发RBD(例如重叠的原发性睡眠障碍)的评估来确定治疗方案和后续方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号